Add BrightSurf on Google Email

Etanercept shows promise for treating dermatomyositis

A multicenter pilot study found etanercept successfully weaned patients from steroid therapy, with no significant increase in adverse event rates. Larger studies are needed to investigate the safety and efficacy of etanercept for dermatomyositis treatment.

SourceWiley·JournalAnnals of Neurology·DateJun 17, 2011

Genes that control 'aging' steroid identified

Researchers have uncovered 8 genes that control the main steroid produced by the adrenal gland, which is believed to play a role in aging and longevity. The study found that these genetic regions are also associated with common age-related diseases, providing the first genetic evidence for the ageing role of the steroid.

SourceKing's College London·JournalPLOS Genetics·DateApr 14, 2011

Embargoed news from Annals of Internal Medicine

Researchers find that oral steroids improve symptoms of chronic rhinosinusitis with polyposis, while surrogate treatment decisions have a significant negative emotional impact on healthcare providers. The Hepatitis B vaccine has reduced infections in children, but targeted efforts are needed for adults. The USPSTF is updating its scree...

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·DateFeb 28, 2011

After 40 years, NIH-supported researchers identify possible new treatment for severe vasculitis

A new treatment strategy using rituximab has shown comparable benefits to the current standard of care in reducing disease activity and inducing remission for patients with ANCA-associated vasculitis. Early results also suggest improved outcomes for patients with relapsing disease, making this a major treatment advance.

SourceNIH/National Institute of Allergy and Infectious Diseases·JournalNew England Journal of Medicine·DateJul 14, 2010

Mount Sinai researchers discover potential treatment for bone death in the hip from osteonecrosis

Researchers at Mount Sinai School of Medicine have found a potential new treatment for osteonecrosis, a debilitating disease caused by steroid use. Injecting ACTH significantly reduced bone death in rabbits with osteonecrosis, promoting increased blood flow to bone cells and preventing cell death.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalProceedings of the National Academy of Sciences·DateApr 27, 2010

Steroids not as effective in obese asthma patients

Researchers at National Jewish Health found that glucocorticoids are 40% less effective in overweight and obese asthma patients than in those of normal weight. The study suggests a potential mechanism involved in the resistance, which could lead to therapeutic targets for future medications.

SourceNational Jewish Health·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateSep 16, 2008

Kidney transplant patients may benefit from going off of certain immunosuppressive drugs

Withdrawing calcineurin inhibitors after kidney transplantation can prolong survival, improve kidney function, and save money compared to lifelong medication use. The study found that treatment with sirolimus plus steroids may be more efficacious and less costly than regimens using calcineurin inhibitors.

SourceAmerican Society of Nephrology·JournalJournal of the American Society of Nephrology·DateJun 18, 2008

Evidence lacking to guide treatment for sudden hearing loss

A systematic review and meta-analysis found little to no scientific evidence supporting the use of steroids or other therapies for treating sudden sensorineural hearing loss. The study suggests that systemic steroids may not be the gold standard of treatment due to severe limitations in existing studies.

SourceJAMA Network·JournalArchives of Otolaryngology - Head and Neck Surgery·DateJun 18, 2007

New study finds anabolic steroids may be addictive

A new study using an animal model suggests that anabolic steroids can be addictive. Hamsters showed a marked preference for testosterone, nandrolone or drostanolone, indicating the drugs' potential for addiction. The research highlights the need for awareness among coaches and mental health professionals about this risk.

Study casts doubt over benefit of oral steroid treatment for attacks of wheeze in young children

A recent study has found that oral steroid treatment for preschool children with viral wheeze may not provide any benefits in reducing respiratory symptoms or hospital admissions. The study analyzed data from over 200 young children and found no difference in symptom scores between those who received prednisolone and placebo. However, ...

SourceThe Lancet_DELETED·JournalThe Lancet·DateOct 30, 2003